The targets were mainly enriched in the complement and coagulation cascades, IL‐17 signaling pathway, prostate cancer, AGE‐RAGE signaling pathway in diabetic complications, and the HIF‐1 signaling pathway (Figure 2J). The gene discussed is IL17A; the disease is prostate carcinoma.